Extensive Biopsies and Transurethral Prostate Resection in Men With Previous Negative Biopsies and High or Increasing Prostate Specific Antigen

Journal of Urology

Volumn 182, Issue 4 SUPPL., 2009, Pages 1342-1349

  Ploussard, Guillaume ^a   Dubosq, Francis ^a   Boublil, Véronique ^a   Allory, Yves ^a   de la Taille, Alexandre ^a   Vordos, Dimitri ^a   Hoznek, Andras ^a   Abbou, Claude Clément ^a   Salomon, Laurent ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

biopsy; prostate; prostate specific antigen; prostatic neoplasms; transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SCORING SYSTEM; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 69749105826     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.06.050     Document Type: Article

References (23)

1. Scattoni V., Zlotta A., Montironi R., et al. Extended and saturation prostatic biopsy in the diagnosis and characterization of prostate cancer: a critical analysis of the literature. Eur Urol 52 (2007) 1309
2. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. European Association of Urology. Eur Urol 53 (2008) 68
3. Elabbady A.A., and Khedr M.M. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol 49 (2006) 49
4. Pelzer A.E., Bektic J., Berger A.P., et al. Are transition zone biopsies still necessary to improve prostate cancer detection?. Results from the Tyrol screening project. Eur Urol 48 (2005) 916
5. Guichard G., Larré S., Gallina A., et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 52 (2007) 430
6. Kitamura H., Masumori N., Tanuma Y., et al. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies?. Int J Urol 9 (2002) 95
7. Ornstein D.K., Rao G.S., Smith D.S., et al. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 157 (1997) 880
8. Puppo P., Introini C., Calvi P., et al. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 49 (2006) 873
9. Zigeuner R., Schips L., Lipsky K., et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 62 (2003) 883
10. Pryor M.B., and Schellhammer P.F. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal guided prostate biopsies. Clin Prostate Cancer 1 (2002) 172
11. Rovner E.S., Schanne F.J., Malkowicz B., et al. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 158 (1997) 138
12. De la Taille A., Antiphon P., Salomon L., et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61 (2003) 1181
13. Djavan B., Mazal P., Zlotta A., et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 47 (2001) 111
14. Ravery V., Goldblatt L., Royer B., et al. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 164 (2000) 393
15. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199
16. Gore J.L., Shariat S.F., Miles B.J., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165 (2001) 1554
17. Naughton C.K., Smith D.S., Humphrey P.A., et al. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 52 (1998) 808
18. Mariappan P., Chong W.L., Sundram M., et al. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity. BJU Int 94 (2004) 307
19. Chon C.H., Lai F.C., McNeal J.E., et al. Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol 167 (2002) 2457
20. Steuber T., Karakiewicz P.I., Augustin H., et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol 173 (2005) 737
21. Campos-Fernandes J.L., Bastien L., Nicolaiew N., et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 55 (2009) 600
22. Marberger M.J., Andersen J.T., Nickel J.C., et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol 38 (2000) 563
23. Van Renterghem K., van Koeveringe G., Achten R., et al. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. Eur Urol 52 (2007) 819